Pencharz Pet-Ct And Nuc Med Reporting Limited

	Page
Balance Sheet	1
Notes to the Financial Statements	2—3

Registered number: 16280670

		28 February 2026
	Notes	£	£
CURRENT ASSETS
Debtors	4	90
Investments	5	31,630
Cash at bank and in hand		9,188

		40,908
Creditors: Amounts Falling Due Within One Year	6	(8,170 )

NET CURRENT ASSETS (LIABILITIES)			32,738

TOTAL ASSETS LESS CURRENT LIABILITIES			32,738

NET ASSETS			32,738

CAPITAL AND RESERVES
Called up share capital	7		100
Profit and Loss Account			32,638

SHAREHOLDERS' FUNDS			32,738

For the period ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

D Pencharz

Director

26/10/2026

The notes on pages 2 to 3 form part of these financial statements.

1. General Information

Pencharz Pet-Ct And Nuc Med Reporting Limited is a private company, limited by shares, incorporated in England & Wales, registered number 16280670 . The registered office is Unit 205 Cervantes House, 5-9 Headstone Road, Harrow, Middlesex, HA1 1PD.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable. Turnover includes revenue earned from the rendering of general medical practice services.

2.3. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

3. Average Number of Employees

Average number of employees, including directors, during the period was: 2

4. Debtors

	28 February 2026
	£
Due within one year
Other debtors	90

5. Current Asset Investments

	28 February 2026
	£
Listed investments	31,630

6. Creditors: Amounts Falling Due Within One Year

	28 February 2026
	£
Other creditors	900
Taxation and social security	7,270

	8,170

Page 2

Page 3

Pencharz Pet-Ct And Nuc Med Reporting Limited

Notes to the Financial Statements (continued)

For the Period 27 February 2025 to 28 February 2026

7. Share Capital

	28 February 2026
	£
Allotted, Called up and fully paid	100

Page 3